Literature DB >> 14698607

Synaptic frailty and clathrin-mediated synaptic vesicle trafficking in Alzheimer's disease.

Pamela J Yao1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14698607     DOI： 10.1016/j.tins.2003.10.012

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN： 0166-2236            Impact factor:   13.837


× No keyword cloud information.
  17 in total

1.  Protein quantification at the single vesicle level reveals that a subset of synaptic vesicle proteins are trafficked with high precision.

Authors:  Sarah A Mutch; Patricia Kensel-Hammes; Jennifer C Gadd; Bryant S Fujimoto; Richard W Allen; Perry G Schiro; Robert M Lorenz; Christopher L Kuyper; Jason S Kuo; Sandra M Bajjalieh; Daniel T Chiu
Journal:  J Neurosci       Date:  2011-01-26       Impact factor: 6.167

2.  Beta-amyloid disrupted synaptic vesicle endocytosis in cultured hippocampal neurons.

Authors:  B L Kelly; A Ferreira
Journal:  Neuroscience       Date:  2007-05-17       Impact factor: 3.590

3.  Mass spectrometry quantification of PICALM and AP180 in human frontal cortex and neural retina.

Authors:  Junjun Chen; Irina A Pikuleva; Illarion V Turko
Journal:  Anal Biochem       Date:  2013-08-13       Impact factor: 3.365

4.  Beta-amyloid-induced dynamin 1 depletion in hippocampal neurons. A potential mechanism for early cognitive decline in Alzheimer disease.

Authors:  Brent L Kelly; Robert Vassar; Adriana Ferreira
Journal:  J Biol Chem       Date:  2005-07-07       Impact factor: 5.157

5.  Rab10 Phosphorylation is a Prominent Pathological Feature in Alzheimer's Disease.

Authors:  Tingxiang Yan; Luwen Wang; Ju Gao; Sandra L Siedlak; Mikayla L Huntley; Pichet Termsarasab; George Perry; Shu G Chen; Xinglong Wang
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

6.  Dynamin 2 gene is a novel susceptibility gene for late-onset Alzheimer disease in non-APOE-epsilon4 carriers.

Authors:  Nuripa Jenishbekovna Aidaralieva; Kouzin Kamino; Ryo Kimura; Mitsuko Yamamoto; Takeshi Morihara; Hiroaki Kazui; Ryota Hashimoto; Toshihisa Tanaka; Takashi Kudo; Tomoyuki Kida; Jun-Ichiro Okuda; Takeshi Uema; Hidehisa Yamagata; Tetsuro Miki; Hiroyasu Akatsu; Kenji Kosaka; Masatoshi Takeda
Journal:  J Hum Genet       Date:  2008-01-31       Impact factor: 3.172

7.  Changes in the expression of genes associated with intraneuronal amyloid-beta and tau in Alzheimer's disease.

Authors:  Robert K Fujimura; Teresita Reiner; Fangchao Ma; Virginia Phillips; Alicia de las Pozas; Dennis W Dickson; Bernard A Roos; Guy A Howard; Carlos Perez-Stable
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 8.  Molecular mechanisms of the conjugated alpha,beta-unsaturated carbonyl derivatives: relevance to neurotoxicity and neurodegenerative diseases.

Authors:  Richard M LoPachin; David S Barber; Terrence Gavin
Journal:  Toxicol Sci       Date:  2007-12-13       Impact factor: 4.849

Review 9.  Pathways towards and away from Alzheimer's disease.

Authors:  Mark P Mattson
Journal:  Nature       Date:  2004-08-05       Impact factor: 49.962

10.  The C-terminal sequence of the large hepatitis delta antigen is variable but retains the ability to bind clathrin.

Authors:  Yu-Cheng Wang; Chi-Ruei Huang; Mei Chao; Szecheng J Lo
Journal:  Virol J       Date:  2009-03-16       Impact factor: 4.099
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.